1 / 19

X Ray Meeting

X Ray Meeting. Surgery Team 1. History. SKW, M/ 48yo Good past health Admitted in June 06 for 1 st episode of RUQ pain, fever and jaundice No previous history of pancreatitis Blood tests: WCC, amylase normal Bilirubin 66,ALP 250,ALT 465. Investigations. USG

gwen
Download Presentation

X Ray Meeting

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. X RayMeeting Surgery Team 1

  2. History • SKW, M/ 48yo • Good past health • Admitted in June 06 for 1 st episode of RUQ pain, fever and jaundice • No previous history of pancreatitis • Blood tests: WCC, amylase normal Bilirubin 66,ALP 250,ALT 465

  3. Investigations • USG • Private CT abdomen

  4. ?Benign or malignant?

  5. Progress • EUS and FNA done in July 06 • 5 cm cystic mass at the head of pancreas with no septum or mural nodule seen • Fluid sent for cytology, CEA and CA 19-9

  6. Progress • Fluid cytology : -ve for malignancy • CA 19.9 845 U/ml • CEA 2.93 ng/ml Impression : ? benign lesion

  7. Progress • Pylorus- preserving pancreatoduodenectomy (PPPD) was performed • Intra-op frozen section: no evidence of malignancy

  8. Progress • Pathology of specimen • borderline mucinous cystadenoma • Moderate dysplasia • Clear resection margin • Post op uneventful, discharged on day 10

  9. Discussion Cystic pancreatic neoplasm

  10. Introduction • Majority of cystic lesion in pancreas are pseudocyst (90-95%) • history of acute/chronic pancreatitis • Cystic neoplasm (< 10%) - various histology (Serous vs mucinous) • Certain grade of malignant potential in those other than serous type

  11. Clinical presentation • Non- specific • Most common presentations • abdominal pain • Jaundice

  12. Investigations • USG – cystic lesion • CT / MRI abdomen • Add diagnostic information only • Features suggestive of malignant potential includes intramural mass, thick wall, cystic dilatation of pancreatic duct not always present

  13. Investigations • EUS +/- FNA • Fluid for cytology, amylase, CEA, CA 19.9

  14. CEA 2.93ng/ml Gastrointestinal Endoscopy Volume 61, No. 3, 2005

  15. EUS +/- FNA • Risk of spillage of tumour cells • EUS alone: morphology inadequate for diagnosis - Fluid cytology :low cellular content • Tumour markers: No published cut-off values for clinical use

  16. Management • Decision of management based on (1) Symptoms (2) Risks of malignancy (3) Surgical risks of patient

  17. Management • Surgical treatment - Mainstay is resection • Low mortality rate • Good prognosis Current concepts: cystic neoplasms of the pancreas, New England Journal of Medicine,Sept 2004

  18. Summary • Case illustrating the challenging differentiation of cystic lesions despite various investigations • In good risks patient, surgical excision is the preferable treatment option • undergo EUS+FNA to guide decision making in patients with moderate surgical risks Brugge. Endoscopy July 2006

  19. The End Thank you!

More Related